Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > News > $5M grant to investigate relationship between gut and lung in respiratory disease

$5M grant to investigate relationship between gut and lung in respiratory disease

Date time 21 October, 2021
News Type News type Media release
Australian researchers have been awarded a $5 million National Health and Medical Research Council (NHMRC) Synergy Grant for a project that will advance knowledge of the gut, microbiomes, metabolites and diet, and their role in both causing and potentially treating inflammatory respiratory diseases, particularly chronic obstructive pulmonary disease (COPD).

Australian researchers have been awarded a $5 million National Health and Medical Research Council (NHMRC) Synergy Grant for a project that will advance knowledge of the gut, microbiomes, metabolites and diet, and their role in both causing and potentially treating inflammatory respiratory diseases, particularly chronic obstructive pulmonary disease (COPD).

A respiratory disease also known as emphysema, COPD is the third leading cause of illness and death worldwide.

Involving investigators from leading medical research organisations and universities, the project will explore ways in which microbiomes, metabolites and immunity in the gut can be therapeutically manipulated to treat COPD.

Chief Investigator of the project, Professor Phil Hansbro (pictured), Director, Centenary UTS Centre for Inflammation (a joint initiative between the Centenary Institute and University of Technology Sydney) said COPD and lung diseases are enormous clinical issues and effective treatments are urgently needed.

“Most respiratory disease studies focus predominantly on the lung. We know, however, that there is microbial and immune crosstalk between the gut and the lungs. Gut diseases induce lung inflammation and are linked to COPD and asthma, and vice versa. New approaches that manipulate gut microbiomes have enormous potential as new therapies for lung diseases,” said Professor Hansbro.

The project will be led by three world-renowned senior investigators in addition to Professor Hansbro. They are Professor Emad El-Omar (UNSW Sydney), Professor Lisa Wood (The University of Newcastle) and Professor Meg Jardine (The University of Sydney).

“Such an ambitious project requires expertise in respiratory disease, gut disease, microbiology, immunology, nutrition and dietetics, clinical studies and trials, engineering, bioinformatics, statistics and multi-omics. We have brought together a top-class team with expertise across a diverse set of research disciplines,” said Professor Hansbro.

Stage one of the project will investigate the physiological linkages within the gut-lung axis–involving organ, microbe, metabolite and immune response interactions. The project will then determine ways in which the gut microbiome can be modulated as potential new therapies for COPD. Treatments could include the ingestion of certain microbes, antibiotics or specifically modified diets. These will then go into clinical trials and the roles of microbiomes and the metabolites that they produce will be defined.

Professor El-Omar, UNSW Microbiome Research Centre said, “This Synergy Grant is a great opportunity to deliver translational benefit to millions of COPD sufferers and demonstrates the emerging power of the microbiome revolution in medicine.”

“Projects like this will identify multiple potential treatments that need to be rigorously evaluated to determine their effectiveness in improving human health. We are excited to apply innovative trial solutions that can handle this complexity and allow us to systematically discover the most effective ways for improving health outcomes,” said Professor Jardine, Director of the University of Sydney’s NHMRC Clinical Trials Centre.

“Understanding the interplay between gut and lung health is critical to the development of new and innovative strategies for managing COPD. This project has the potential to lead to a paradigm shift in how we understand COPD,” said Professor Wood, University of Newcastle.

Supporting outstanding multidisciplinary teams of investigators working together, Synergy Grants are awarded by the NHMRC and look to answer major questions that cannot be answered by a single investigator.

Themes

  • Inflammation

    Inflammation

Programs

  • Centenary UTS Centre for Inflammation

People

  • Professor Philip Hansbro

    Deputy Director, Centenary Institute. Director, Centenary UTS Centre for Inflammation

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Download

Recent Stories

  • Metastatic cancer research boosted

    Dr Dannel Yeo from the Centenary Institute and Clinical Associate Professor Kate Mahon from Chris O’Brien Lifehouse, have been awarded an inaugural Sydney Cancer Partners Translational Fellowship.
    News Type: Research News
    Date 03 Mar 2023
  • The Year That Made Me: Professor John Rasko

    Professor John Rasko AO, Head of the Gene and Stem Cell Therapy Program at the Centenary Institute has featured on the popular Radio National show Sunday Extra in the segment called ‘The Year That Made Me’.
    News Type: Media coverage
    Date 21 Feb 2023
  • Top abstract prize for gene therapy research

    Professor John Rasko AO and team have received the top scoring abstract award at the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders in Manchester.
    News Type: Research News
    Date 15 Feb 2023
  • Event celebrates ‘The Good Gut Anti-Inflammatory Diet’

    The Centenary Institute has celebrated the publication of a new book, 'The Good Gut Anti-Inflammatory Diet’ at a special event, held at the Dymocks Bookstore, Sydney.
    News Type: Community
    Date 13 Feb 2023

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram